Thermal monitoring: Invasive, minimal-invasive and non-invasive approaches

Background: Thermal treatments need verification of effectiveness. Invasive intra-tumoural thermometry was established as a standard method several years ago. However, in deep heating, invasive techniques have disadvantages. Therefore, alternatives have been suggested and are under development. Methods: In three phase II studies treating rectal cancer, cervical cancer and prostate cancer, this study replaced invasive (intra-tumoural) thermometry by tumour-related reference points or catheter sections in the rectum, vagina or urethra. Index temperatures and thermal dose parameters were determined. Two recent studies treated patients with recurrent rectal cancer and soft tissue sarcoma using non-invasive MR-thermometry employing the SIGMA-Eye applicator. The proton resonance frequency shift (PRFS) method was employed to generate MR-temperature distributions during the entire heat treatment in 10 min intervals (via phase differences). Fat correction (nulling specified regions in the fat tissue) was utilized to calibrate the method, in particular with respect to the B0-drift. Results: Statistically significant correlations were found between response (downstaging, WHO) and thermal parameters in rectal cancer (37 patients, rectum measurement, T90, cum min T90 ≥ 40.5°C) and cervical cancer (30 patients, vagina, mean temperature and equ min 43°C in a reference point). In prostate cancer (14 patients), a clear correlation was verified between long-term PSA control (≤1 ng ml−1) and urethral temperatures (T90, Tmax cum min T90 ≥ 40.5°C). The mean MR-temperature in the tumour at steady-state as well as the mean T90 were significantly correlated with response for recurrent rectal carcinoma regarding palliation and analgesia (15 patients) and with pathohistological regression rate in soft tissue sarcoma (nine patients). Conclusions: For tumours in the pelvis and in the lower extremities, invasive measurements can be replaced by minimally-invasive or non-invasive techniques, which provide equivalent or even more complete information. Extending the application of these surveillance methods to abdominal tumours or liver metastases is a challenge, but strongly desirable for clinical reasons.

[1]  J W Hand,et al.  Quality assurance guidelines for ESHO protocols. , 1989, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[2]  P. Deuflhard,et al.  Clinical evaluation and verification of the hyperthermia treatment planning system hyperplan. , 2000, International journal of radiation oncology, biology, physics.

[3]  M. Seebass,et al.  Teilkörperhyperthermie mit einem Radiofrequenz-Multiantennen-Applikator unter online Kontrolle in einem 1,5 T MR-Tomographen , 2004, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[4]  M. Seebass,et al.  Clinical, physiological and anatomical determinants for radiofrequency hyperthermia. , 1995, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[5]  P M Schlag,et al.  Preoperative hyperthermia combined with radiochemotherapy in locally advanced rectal cancer: a phase II clinical trial. , 1998, Annals of surgery.

[6]  S L George,et al.  Cumulative minutes with T90 greater than Tempindex is predictive of response of superficial malignancies to hyperthermia and radiation. , 1993, International journal of radiation oncology, biology, physics.

[7]  P M Schlag,et al.  Preoperative radiochemotherapy in locally advanced or recurrent rectal cancer: regional radiofrequency hyperthermia correlates with clinical parameters. , 2000, International journal of radiation oncology, biology, physics.

[8]  W. Wilmanns,et al.  Ifosfamide plus etoposide combined with regional hyperthermia in patients with locally advanced sarcomas: a phase II study. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  P. Wust,et al.  Regional Hyperthermia in Conjunction with Definitive Radiotherapy against Recurrent or Locally Advanced Prostate Cancer T3 pN0 M0 , 2005, Strahlentherapie und Onkologie.

[10]  P. Wust,et al.  Temperature data and specific absorption rates in pelvic tumours: predictive factors and correlations. , 2001, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[11]  M. Édgar,et al.  Progressive growth stages in the development of spontaneous thyroid tumors in inbred swordtails Xiphophorus montezumae. , 1953, Cancer research.

[12]  J R Oleson,et al.  Tumor temperature distributions predict hyperthermia effect. , 1989, International journal of radiation oncology, biology, physics.

[13]  P Wust,et al.  Rationale for using invasive thermometry for regional hyperthermia of pelvic tumors. , 1998, International journal of radiation oncology, biology, physics.

[14]  Peter Schlag,et al.  Clinical use of the hyperthermia treatment planning system HyperPlan to predict effectiveness and toxicity. , 2003, International journal of radiation oncology, biology, physics.

[15]  W. Dewey Arrhenius relationships from the molecule and cell to the clinic. , 1994, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[16]  Peter Wust,et al.  Radiochemotherapy combined with regional pelvic hyperthermia induces high response and resectability rates in patients with nonresectable cervical cancer > or =FIGO IIB "bulky". , 2006, International journal of radiation oncology, biology, physics.

[17]  Waldemar Wlodarczyk,et al.  Noninvasive magnetic resonance thermography of recurrent rectal carcinoma in a 1.5 Tesla hybrid system. , 2005, Cancer research.

[18]  P. Wust,et al.  Methods and potentials of magnetic resonance imaging for monitoring radiofrequency hyperthermia in a hybrid system , 2005, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[19]  P Wust,et al.  ESHO quality assurance guidelines for regional hyperthermia. , 1998, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[20]  Waldemar Wlodarczyk,et al.  A practical approach to thermography in a hyperthermia/magnetic resonance hybrid system: validation in a heterogeneous phantom. , 2005, International journal of radiation oncology, biology, physics.

[21]  J. van der Zee,et al.  Practical limitations of interstitial thermometry during deep hyperthermia. , 1998, International journal of radiation oncology, biology, physics.